サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：創傷治療市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1326476

創傷治療市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Wound Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Therapy, By Wound Type, By Application, By End User, By Region and Competition

出版日
ページ情報
英文 118 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

創傷治療市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の創傷治療市場は、創傷治療の重要性に対する意識の高まりと創傷治療技術の進歩により、予測期間中に目覚ましい成長が見込まれています。

長年にわたり、世界の創傷治療市場は、慢性創傷の増加や新しく革新的な創傷治療製品の開発により大きな成長を遂げてきました。例えば、創傷治療における幹細胞の利用は盛んに研究されており、多くの企業が幹細胞ベースの創傷治療製品を開発しています。創傷治療技術におけるその他の進歩には、3Dプリント創傷被覆材、創傷治療をモニターできるスマート被覆材、生体接着剤を使用した創傷閉鎖器具などの開発が含まれます。

慢性創傷の増加

慢性創傷は世界の創傷治療市場の主要な促進要因であり、市場全体のかなりの部分を占めています。米国疾病予防管理センター（CDC）によると、米国では約650万人が慢性創傷を患っており、これらの創傷治療にかかる年間コストは281億～317億米ドルと推定されています。創傷管理にかかる総費用には、消耗品やドレッシング材、看護時間、ホスピタリティなどが含まれます。創傷被覆材を何度も交換することで創傷治療の総費用がかさむため、より高度な創傷治療オプションの開拓が必要となり、それが世界の創傷治療市場の成長を支えています。

新たな創傷治療技術

従来の方法による創傷治療には高いコストがかかるため、細胞を使った治療や皮膚の代用品、バイオマテリアルでできた創傷被覆材の使用など、新しく革新的な治療法の開発が進んでいます。

細胞は創傷治療に不可欠な要素であり、その利用は創傷治療へのアプローチ方法に革命をもたらしました。創傷とは、皮膚や粘膜を破る開放性の傷のことで、外傷、手術、慢性疾患など様々な要因によって引き起こされます。身体の創傷治療能力は、創傷の程度や部位、患者の健康状態、基礎疾患の有無など、様々な要因に左右されます。細胞は傷ついた組織を補い、新しい組織の成長を促進することで、創傷治療プロセスにおいて重要な役割を果たしています。細胞は、細胞ベース治療、幹細胞、代用皮膚など、様々な形で治癒プロセスを促進するために使用されます。細胞を用いた治療では、生きた細胞を用いて治癒を促進し、損傷した組織の機能を改善します。これらの治療法は、従来の創傷治療を行っても治癒しない慢性創傷にしばしば用いられます。創傷治療の促進には、線維芽細胞、ケラチノサイト、内皮細胞など、さまざまな種類の細胞を用いることができます。線維芽細胞は、組織に強度と構造を与えるタンパク質であるコラーゲンを産生する細胞です。ケラチノサイトは、皮膚の必須成分であるタンパク質、ケラチンを産生する細胞です。内皮細胞は血管を覆う細胞で、創傷床における新しい血管の形成に重要な役割を果たします。

創傷治療における細胞の使用は、世界の創傷治療市場全体に革命を起こす可能性を秘めています。これらの治療法は従来の創傷治療法に比べていくつかの利点があり、患者の転帰を大幅に改善する可能性を秘めています。再生医療の分野が発展し続けるにつれ、創傷治療における細胞の使用はますます一般的になり、慢性創傷に苦しむ患者に新たな希望を提供し、今後数年間で世界の創傷治療市場の成長に新たな展望をもたらすと思われます。

代替創傷治療法

新たな創傷治療法とは別に、圧迫療法、創傷陰圧療法、高気圧酸素療法など、いくつかの代替創傷治療法が用いられています。これらの治療法は、今後数年間で代替創傷治療療法市場の成長に新たな展望を開くと期待されています。圧迫療法は、出血傾向のある創傷や血栓発生のリスクのある創傷の治療に用いられます。この方法には、圧迫包帯やストッキングを用いて創傷に圧力を加えることが含まれます。圧迫療法は、静脈性潰瘍や深部静脈血栓症など、四肢の創傷に最も適しています。陰圧創傷治療は、より高度な創傷治療で、大きな慢性創傷に用いられます。この方法では、傷口を真空状態にすることで、余分な水分を除去し血流を増加させることで治癒を促進します。陰圧創傷治療は、治癒が遅れている創傷や感染する危険性のある創傷に最も適しています。高気圧酸素療法は、血流が悪いために治癒しない創傷に用いられる特殊な創傷治療法です。この方法では、傷口を高濃度の酸素にさらすことで、血流を増加させ、新しい組織の成長を促進することで治癒を促します。高気圧酸素療法は、大きく慢性的な創傷に最も適しています。

最近の動向

  • モルンリッケ・ヘルスケア AB 2021年英国に新しい流通センターを開設。これにより、同社製品への顧客アクセスが向上し、販売強化につながります。
  • 3M Company 2021は、3M Spunlace Extended Wear Adhesive Tape on Liner, 4576として知られる新しい粘着テープを発売しました。この新製品は装着時間が約21日間で、ユーザーのコンプライアンスと健康上のメリットを提供すると同時に、創傷治療のコストを最適化するのに役立ちます。

利用可能なカスタマイズ

TechSci Researchでは、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

  • 調査目的
  • ベースライン調査手法
  • 主要産業パートナー
  • 主要協会と二次情報源
  • 予測手法
  • データの三角測量と検証
  • 仮定と限界

第3章 エグゼクティブサマリー

  • 市場概要
  • 主要市場セグメンテーションの概要
  • 主要市場プレーヤーの概要
  • 主要地域/国の概要
  • 市場促進要因・課題・動向の概要

第4章 顧客の声

第5章 臨床試験分析

第6章 創傷治療の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 治療法別（機器療法、血小板療法、細胞療法、創傷被覆材、その他）
    • 創傷タイプ別（腹部皮下創傷、外傷性・感染性創傷、両側乳房縮小術創傷、その他）
    • 用途別（熱傷、潰瘍、切り傷・裂傷、その他）
    • エンドユーザー別（病院,外来手術センター,在宅医療,その他）
    • 地域別
    • 企業別（2022）
  • 製品マップ
    • 治療法別
    • 創傷タイプ別
    • 用途別
    • エンドユーザー別
    • 地域別

第7章 北米創傷治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 治療法別
    • 創傷タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の創傷治療市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 治療法別
    • 創傷タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域の創傷治療市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 治療法別
    • 創傷タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の創傷治療市場展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 治療法別
    • 創傷タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの創傷治療市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • 治療法別
    • 創傷タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品上市

第14章 創傷治療の世界市場SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
    • 3M Company
    • ConvaTec Group PLC
    • Molnlycke Health Care AB
    • Smith & Nephew plc
    • Organogenesis, Inc
    • Coloplast A/S.
    • MiMedx Group, Inc.
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Medtronic Plc.

第17章 戦略的提言

目次
Product Code: 14829

Global Wound Treatment Market is expected to grow at an impressive rate during the forecast period on account of the increasing awareness of the importance of wound care and advances in wound treatment technologies. Over the years, the global wound treatment market has witnessed significant growth on account of the increasing incidences of chronic wounds and the development of new and innovative wound care products. For example, the use of stem cells in wound healing is an area of intense research, with many companies developing stem cell-based wound care products. Other advances in wound care technology include the development of 3D-printed wound dressings, smart dressings that can monitor wound healing, and wound closure devices that use bioadhesives.

The wound treatment market is also being driven by the increasing use of wound care products in surgical procedures. Advances in wound care technology have made it possible to use wound care products to improve outcomes in surgical procedures, leading to an increase in the use of these products in the operating room.

Increasing Incidence of Chronic Wounds

Chronic wounds are a major driver of the global wound treatment market, accounting for a significant portion of the total market. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people in the United States suffer from chronic wounds, and the annual cost of treating these wounds is estimated to be between USD 28.1 billion and USD 31.7 billion. The overall cost of wound management includes supplies and dressings, nursing time, and hospitalization. Changing the wound dressings again and again adds up to the overall cost of wound care, thereby creating a need for the development of more advanced wound treatment options, hence supporting the growth of global wound treatment market.

Emerging Wound Treatment Techniques

The high cost of wound treatment using traditional methods has led to the development of new and innovative therapies, such as cell-based treatments or skin substitutes or using wound dressings made up of biomaterials, among others.

Cells are an integral part of wound treatment, and their use has revolutionized the way we approach wound healing. Wounds are open injury that breaks the skin or mucous membranes and can be caused by various factors such as trauma, surgery, or chronic diseases. The ability of the body to heal wounds is dependent on various factors, such as the extent and location of the wound, the patient's health status, and the presence of any underlying medical conditions. Cells play a crucial role in the wound-healing process by replacing damaged tissue and promoting the growth of new tissue. They can be used in a variety of forms, including cell-based therapies, stem cells, and skin substitutes, to enhance the healing process. Cell-based therapies involve using living cells to promote healing and improve the function of the damaged tissue. These therapies are often used in chronic wounds, which fail to heal even after conventional wound care. Different types of cells, including fibroblasts, keratinocytes, and endothelial cells, can be used to promote wound healing. Fibroblasts are cells that produce collagen, a protein that gives strength and structure to tissues. Keratinocytes are cells that produce keratin, a protein that is an essential component of skin. Endothelial cells are cells that line the blood vessels and play a vital role in the formation of new blood vessels in the wound bed.

The use of cells in wound treatment has the potential to revolutionize the overall global wound treatment market. These therapies offer several advantages over traditional wound care methods and have the potential to significantly improve patient outcomes. As the field of regenerative medicine continues to evolve, the use of cells in wound treatment is likely to become increasingly common, offering new hope for patients suffering from chronic wounds and creating new prospects for the growth of global wound treatment market in the coming years.

Alternative Wound Treatment Therapies

Apart from the emerging wound treatments, there are several alternative wound treatment therapies, such as compression therapy, negative wound pressure therapy, and hyperbaric oxygen therapy, which are being used. These therapies are, in turn, expected to open new prospects for the growth of the alternative wound treatment therapies market in the coming years. Compression therapy is used to treat wounds that have a tendency to bleed or are at risk of developing blood clots. This method involves applying pressure to the wound using compression bandages or stockings. Compression therapy is most appropriate for wounds that are on the limbs, such as venous ulcers and deep vein thrombosis. Negative pressure wound therapy is a more advanced form of wound treatment that is used for large, chronic wounds. This method involves applying a vacuum to the wound, which promotes healing by removing excess fluid and increasing blood flow. Negative pressure wound therapy is most appropriate for wounds that are not healing or are at risk of becoming infected. Hyperbaric oxygen therapy is a specialized form of wound treatment that is used for wounds that are not healing due to poor blood flow. This method involves exposing the wound to high levels of oxygen, which promotes healing by increasing blood flow and promoting the growth of new tissue. Hyperbaric oxygen therapy is most appropriate for wounds that are large and chronic.

Market Segmentation

Global Wound Treatment Market can be segmented by therapy, wound type, application, end-user, and by region. Based on therapy, global wound treatment market can be categorized into instrumental-based therapy, platelet therapy, cell therapy, and wound dressings. By wound type, the global wound treatment market can be segmented into subcutaneous abdominal wounds, traumatic & infected wounds, bilateral reduction mammaplasty, and others. In terms of application, global wound treatment market can be grouped into burns, ulcers, cuts & lacerations, and others. By end user, the global wound treatment market can be grouped into hospitals & clinics, ambulatory surgery centers, homecare, and others. Regionally, global wound treatment market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America. The United States dominated the North America market in 2022 and the overall global wound treatment market over other countries on account of the rising patient pool in the country coupled with an increasing geriatric population base which is at a higher risk of developing wounds. This, in turn, is expected to increase the demand for different wound care methods and products, thereby driving the growth of global wound treatment market. According to the Administration for Community Living, which includes the Administration on Aging, which is an operating division of the U.S. Department of Health and Human Services, the population aged 65 and above reached 54.1 million in 2019 from 39.6 million in 2009 and is projected to reach 94.7 million in 2060. By 2040, there will be about 80.8 million older persons, more than twice as many as in 2000. The growing geriatric population will support the growth of global wound treatment market in the coming years. However, the Asia Pacific region is expected to register the highest growth during the forecast period on account of the increasing prevalence of various chronic diseases in the region, especially in the highly populous countries of China and India.

Market Players

3M Company, ConvaTec Group PLC, Molnlycke Health Care AB, Smith & Nephew plc, Organogenesis, Inc, Coloplast A/S, MiMedx Group, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic Plc., among others are some of the leading players operating in the global wound treatment market.

Recent Developments

  • Molnlycke Health Care AB 2021 launched a new distribution center in the United Kingdom. This, in turn, will help the company strengthen its sales by increasing customer access to its products.
  • 3M Company 2021 launched a new adhesive tape known as 3M Spunlace Extended Wear Adhesive Tape on Liner, 4576. This new product has a wear time of around 21 days which helps in providing user compliance and health benefits while at the same time optimizing the cost of wound treatment.

Report Scope:

In this report, Global Wound Treatment Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Wound Treatment Market, By Type:

  • Instrumental Based Therapy
  • Platelet Therapy
  • Cell Therapy
  • Wound Dressing
  • Others

Wound Treatment Market, By Wound Type:

  • Subcutaneous Abdominal Wound
  • Traumatic & Infected Wound
  • Bilateral Reduction Mammaplasty Wound
  • Others

Wound Treatment Market, By Application:

  • Burns
  • Ulcers
  • Cuts & Lacerations
  • Others

Wound Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Homecare
  • Others

Wound Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Wound Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Wound Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy (Instrumental Based Therapy, Platelet Therapy, Cell Therapy, Wound Dressing, Others)
    • 6.2.2. By Wound Type (Subcutaneous Abdominal Wound, Traumatic & Infected Wound, Bilateral Reduction Mammaplasty Wound, Others)
    • 6.2.3. By Application (Burns, Ulcers, Cuts & Lacerations, Others)
    • 6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Homecare, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2022)
  • 6.3. Product Map
    • 6.3.1 By Therapy
    • 6.3.2 By Wound Type
    • 6.3.4 By Application
    • 6.3.5 By End User
    • 6.3.6 By Region

7. North America Wound Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy
    • 7.2.2. By Wound Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Wound Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Wound Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Wound Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Wound Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy
    • 8.2.2. By Wound Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Wound Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Wound Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Wound Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecasty
        • 8.3.3.2.1. By Therapy
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Wound Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Wound Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Wound Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy
    • 9.2.2. By Wound Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Wound Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Wound Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Wound Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Wound Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapy
        • 9.3.4.2.2. By Wound Type
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Wound Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapy
        • 9.3.5.2.2. By Wound Type
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Wound Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy
    • 10.2.2. By Wound Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Wound Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Wound Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Wound Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Wound Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapy
    • 11.2.2. By Wound Type
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Wound Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapy
        • 11.3.1.2.2. By Wound Type
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Wound Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapy
        • 11.3.2.2.2. By Wound Type
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Wound Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapy
        • 11.3.3.2.2. By Wound Type
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Development
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Wound Treatment Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Product Offerings
  • 16.3. Recent Developments
  • 16.4. Financials (As Reported)
  • 16.5. Key Personnel
    • 16.5.1. 3M Company
    • 16.5.2. ConvaTec Group PLC
    • 16.5.3. Molnlycke Health Care AB
    • 16.5.4. Smith & Nephew plc
    • 16.5.5. Organogenesis, Inc
    • 16.5.6. Coloplast A/S.
    • 16.5.7. MiMedx Group, Inc.
    • 16.5.8. Integra LifeSciences Corporation
    • 16.5.9. Johnson & Johnson
    • 16.5.10. Medtronic Plc.

17. Strategic Recommendations